Ionis Pharmaceuticals Inc
(NAS:IONS)
$
35.91
-0.42 (-1.16%)
Market Cap: 5.74 Bil
Enterprise Value: 4.73 Bil
PE Ratio: 0
PB Ratio: 8.65
GF Score: 40/100 Ionis Pharmaceuticals Inc at Cowen Health Care Conference Transcript
Mar 13, 2019 / 02:00PM GMT
Release Date Price:
$76.61
(+2.31%)
Ritu Subhalaksmi Baral
Cowen and Company, LLC, Research Division - MD and Senior Biotechnology Analyst
Thanks. I think we're live now. Thank you, everyone, for joining us on this last day of the 39th Annual Cowen Health Care Conference and for the Ionis fireside chat. I'm covering analyst Ritu Baral. And with me today is COO and incoming CEO as of January 2020, Brett Monia. Welcome, Brett. Thanks for doing this with us.
Brett P. Monia
Ionis Pharmaceuticals, Inc. - Founder, COO & Senior VP of Translational Medicine
Thank you, Ritu.
Questions & Answers
Ritu Subhalaksmi Baral
Cowen and Company, LLC, Research Division - MD and Senior Biotechnology Analyst
Let's start with a 30,000-foot view on the company before going down to individual investment drivers. You're expecting to be bottom line profitable this year per your last earnings. And beyond that, you're estimating sustained profitability going forward. Your accountant seems to be estimating that as well, since you're actually getting to book some
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot